ZipBio

Seattle, United States

ZipBio develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.

$4.0M raised

Sep 2024

Seed

Top Investors

NFXMoreVC

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ZipBio raised?

ZipBio has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in September 2024.

Who are ZipBio's investors?

ZipBio's investors include NFX, MoreVC.

Where is ZipBio headquartered?

ZipBio is headquartered in Seattle, United States.

What does ZipBio do?

ZipBio develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.

What stage is ZipBio at?

ZipBio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 5, 2024.

MLA

"ZipBio — Funding & Investors." VCBacked, September 5, 2024, https://www.vcbacked.co/company/zipbio. Accessed June 17, 2026.

APA

VCBacked. (2024). ZipBio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/zipbio

Wikipedia (cite web)

{{cite web |title=ZipBio — Funding & Investors |url=https://www.vcbacked.co/company/zipbio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 5, 2024.